Invasive pulmonary aspergillosis and pulmonary cryptococcosis really coexist in immunocompromised host

Journal of Infection

Volumn 53, Issue 2, 2006, Pages

  Lin, Chih Ming ^a   Tsai, Ying Huang ^a   Huang, Chung Chi ^a   Lee, Cheng Huei ^a   Chiang, Ping Cherng ^a   Huang, Shiu Feng ^a,b   Liu, Hui Ping ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Aspergillosis; Cryptococcosis; Immunocompromised; Lung biopsy

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; FLUCONAZOLE; GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; ASPERGILLUS FLAVUS; CASE REPORT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCOSIS; CRYPTOCOCCUS; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOTHERAPY; LUNG ASPERGILLOSIS; LUNG BIOPSY; LUNG PARENCHYMA; NONHUMAN; PNEUMONIA; PNEUMOTHORAX; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX DRAINAGE; THORAX RADIOGRAPHY; THORAX SURGERY;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CRYPTOCOCCOSIS; FEMALE; FLUCONAZOLE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, FUNGAL; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 33745831911     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.10.017     Document Type: Article

References (9)

1. Kenneth J., Hammerman K.E., and Powell C.S. Pulmonary cryptococcosis: clinical forms and treatment. Am Rev Respir Dis 108 (1973) 1116-1123
2. Tang C.M., and Cohen J. Diagnosing fungal infections in immunocompromised hosts. J Clin Pathol 45 (1992) 1-5
3. Shorr A.F., Susla G.M., and O'Grady N.P. Pulmonary infiltrates in the non-HIV infected immunocompromised patient. Chest 125 (2004) 260-271
4. Patterson T.F., Kirkpatrick W.R., and White M. Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. Medicine 79 (2000) 250-260
5. Jain P., Sandur S., Meli Y., Arroliga A.C., Stoller J.K., and Metita A.C. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 125 (2004) 712-722
6. Rano A., Agusti C., Jimenez P., Angrill J., Benito N., Danes C., et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using noninvasive and bronchoscopic procedures. Thorax 56 (2001) 379-387
7. White D.A., Wong P.W., and Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 161 (2000) 723-729
8. Toledo-Pereyra L.H., DeMeester T.R., Kinealey A., MacMahon H., Churg A., and Golomb H. The benefits of open lung biopsy in patients with previous non-diagnostic transbronchial lung biopsy. A guide to appropriate therapy. Chest 77 (1980) 647-650
9. Yamazaki T., Kume H., and Murase S. Epidemiology of visceral mycoses: analysis of data in Annual of the Pathological Autopsy Cases in Japan. J Clin Microbiol 37 (1999) 1732-1738